US Stock MarketDetailed Quotes

NewAmsterdam Pharma (NAMS)

Watchlist

34.680
+1.480+4.46%

Close Apr 17 16:00 ET

34.680
0.0000.00%

Post 16:47 ET

3.99BMarket Cap-20.16P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NewAmsterdam Pharma (NAMS) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

6.80%-147.78M

-9.06%-40.88M

-162.11%-32.77M

30.21%-37.67M

33.21%-36.47M

-12.28%-158.56M

-13.32%-37.48M

73.39%-12.5M

-84.20%-53.98M

-71.36%-54.6M

Net income from continuing operations

15.64%-203.82M

18.72%-74.92M

-332.54%-72.01M

55.48%-17.36M

57.85%-39.53M

-36.54%-241.6M

-86.23%-92.18M

64.68%-16.65M

-1.87%-39.01M

-123.16%-93.77M

Operating gains losses

-93.02%5.74M

-71.13%15.43M

702.63%23.58M

-28.95%-11.22M

-153.29%-22.05M

1,472.73%82.19M

4,931.36%53.43M

-717.03%-3.91M

-2,161.14%-8.7M

1,231.02%41.37M

Depreciation and amortization

94.69%220K

15.69%59K

128.57%64K

136.84%45K

246.67%52K

130.61%113K

292.31%51K

100.00%28K

46.15%19K

66.67%15K

Other non cash items

----

--0

200.00%3K

100.00%12K

300.00%4K

150.00%5K

100.00%2K

-50.00%1K

Change In working capital

75.69%-7.94M

157.21%4.57M

3,410.71%983K

-63.48%-23.84M

202.11%10.35M

-657.01%-32.67M

-185.45%-7.98M

100.48%28K

-587.47%-14.59M

-1,647.76%-10.14M

-Change in prepaid assets

23.94%-13.28M

-15.81%-10.06M

630.22%2.61M

-136.80%-21.86M

1,576.88%16.03M

-533.12%-17.46M

-385.57%-8.69M

83.84%-493K

-269.36%-9.23M

167.66%956K

-Change in payables and accrued expense

165.33%7.36M

1,425.28%10.64M

-170.70%-1.63M

134.09%1.05M

72.12%-2.7M

-206.85%-11.26M

-111.31%-803K

2,056.07%2.31M

-314.29%-3.07M

-337.72%-9.69M

-Change in other working capital

48.87%-2.02M

163.52%3.99M

--0

-32.95%-3.03M

-112.56%-2.98M

54.59%-3.95M

288.65%1.51M

39.29%-1.79M

-32.73%-2.28M

56.81%-1.4M

Cash from discontinued investing activities

Operating cash flow

6.80%-147.78M

-9.06%-40.88M

-162.11%-32.77M

30.21%-37.67M

33.21%-36.47M

-12.28%-158.56M

-13.32%-37.48M

73.39%-12.5M

-84.20%-53.98M

-71.36%-54.6M

Investing cash flow

Cash flow from continuing investing activities

-178.32%-174.92M

66.00%-21.14M

3,441.33%2.51M

-76,041.63%-159.14M

841.56%2.86M

-261,766.67%-62.85M

-2,072,533.33%-62.18M

-733.33%-75K

-4,080.00%-209K

-5,400.00%-385K

Net PPE purchase and sale

63.39%-246K

-3,233.33%-100K

44.00%-42K

57.89%-88K

95.84%-16K

-2,700.00%-672K

0.00%-3K

-733.33%-75K

-4,080.00%-209K

-5,400.00%-385K

Net investment purchase and sale

-180.93%-174.67M

66.16%-21.04M

--2.55M

---159.05M

--2.87M

---62.18M

--0

Cash from discontinued investing activities

Investing cash flow

-178.32%-174.92M

66.00%-21.14M

3,441.33%2.51M

-76,041.63%-159.14M

841.56%2.86M

-261,766.67%-62.85M

-2,072,533.33%-62.18M

-733.33%-75K

-4,080.00%-209K

-5,400.00%-385K

Financing cash flow

Cash flow from continuing financing activities

-95.52%29.52M

-97.00%13.68M

10,058.62%5.89M

-26.47%3.43M

-96.71%6.52M

7,300.21%659.51M

456.61M

-68.82%58K

-26.46%4.66M

8,185.12%198.18M

Net issuance payments of debt

----

--0

----

Net common stock issuance

--0

--645.51M

--455.03M

--0

--190.48M

Proceeds from stock option exercised by employees

100.31%31.11M

749.94%13.68M

10,058.62%5.89M

-26.47%3.43M

-11.93%8.11M

74.25%15.53M

--1.61M

-68.82%58K

-26.46%4.66M

284.74%9.2M

Net other financing activities

-3.73%-1.59M

--0

-5.45%-1.59M

---1.53M

---25K

--0

---1.5M

Cash from discontinued financing activities

Financing cash flow

-95.52%29.52M

-97.00%13.68M

10,058.62%5.89M

-26.47%3.43M

-96.71%6.52M

7,300.21%659.51M

--456.61M

-68.82%58K

-26.46%4.66M

8,185.12%198.18M

Net cash flow

Beginning cash position

126.68%771.74M

27.67%539.72M

30.92%563.86M

55.55%748.42M

126.68%771.74M

-27.21%340.45M

14.78%422.73M

3.36%430.71M

9.03%481.15M

-27.21%340.45M

Current changes in cash

-166.92%-293.18M

-113.54%-48.33M

-94.67%-24.37M

-290.43%-193.38M

-118.92%-27.09M

431.06%438.1M

1,179.15%356.95M

73.25%-12.52M

-115.57%-49.53M

585.76%143.19M

Effect of exchange rate changes

287.58%12.76M

99.24%-60K

-95.11%222K

1,070.96%8.83M

251.08%3.77M

-234.64%-6.8M

-252.05%-7.94M

383.75%4.54M

44.23%-909K

-181.52%-2.5M

End cash Position

-36.34%491.32M

27.67%539.72M

30.92%563.86M

55.55%748.42M

126.68%771.74M

14.78%422.73M

3.36%430.71M

9.03%481.15M

Free cash flow

7.04%-148.03M

-9.31%-40.98M

-160.88%-32.81M

30.32%-37.76M

33.65%-36.48M

-12.74%-159.24M

-13.32%-37.48M

73.23%-12.58M

-84.88%-54.19M

-72.54%-54.99M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	6.80%-147.78M	-9.06%-40.88M	-162.11%-32.77M	30.21%-37.67M	33.21%-36.47M	-12.28%-158.56M	-13.32%-37.48M	73.39%-12.5M	-84.20%-53.98M	-71.36%-54.6M
Net income from continuing operations	15.64%-203.82M	18.72%-74.92M	-332.54%-72.01M	55.48%-17.36M	57.85%-39.53M	-36.54%-241.6M	-86.23%-92.18M	64.68%-16.65M	-1.87%-39.01M	-123.16%-93.77M
Operating gains losses	-93.02%5.74M	-71.13%15.43M	702.63%23.58M	-28.95%-11.22M	-153.29%-22.05M	1,472.73%82.19M	4,931.36%53.43M	-717.03%-3.91M	-2,161.14%-8.7M	1,231.02%41.37M
Depreciation and amortization	94.69%220K	15.69%59K	128.57%64K	136.84%45K	246.67%52K	130.61%113K	292.31%51K	100.00%28K	46.15%19K	66.67%15K
Other non cash items	----	----	--0	--0	200.00%3K	100.00%12K	300.00%4K	150.00%5K	100.00%2K	-50.00%1K
Change In working capital	75.69%-7.94M	157.21%4.57M	3,410.71%983K	-63.48%-23.84M	202.11%10.35M	-657.01%-32.67M	-185.45%-7.98M	100.48%28K	-587.47%-14.59M	-1,647.76%-10.14M
-Change in prepaid assets	23.94%-13.28M	-15.81%-10.06M	630.22%2.61M	-136.80%-21.86M	1,576.88%16.03M	-533.12%-17.46M	-385.57%-8.69M	83.84%-493K	-269.36%-9.23M	167.66%956K
-Change in payables and accrued expense	165.33%7.36M	1,425.28%10.64M	-170.70%-1.63M	134.09%1.05M	72.12%-2.7M	-206.85%-11.26M	-111.31%-803K	2,056.07%2.31M	-314.29%-3.07M	-337.72%-9.69M
-Change in other working capital	48.87%-2.02M	163.52%3.99M	--0	-32.95%-3.03M	-112.56%-2.98M	54.59%-3.95M	288.65%1.51M	39.29%-1.79M	-32.73%-2.28M	56.81%-1.4M
Cash from discontinued investing activities
Operating cash flow	6.80%-147.78M	-9.06%-40.88M	-162.11%-32.77M	30.21%-37.67M	33.21%-36.47M	-12.28%-158.56M	-13.32%-37.48M	73.39%-12.5M	-84.20%-53.98M	-71.36%-54.6M
Investing cash flow
Cash flow from continuing investing activities	-178.32%-174.92M	66.00%-21.14M	3,441.33%2.51M	-76,041.63%-159.14M	841.56%2.86M	-261,766.67%-62.85M	-2,072,533.33%-62.18M	-733.33%-75K	-4,080.00%-209K	-5,400.00%-385K
Net PPE purchase and sale	63.39%-246K	-3,233.33%-100K	44.00%-42K	57.89%-88K	95.84%-16K	-2,700.00%-672K	0.00%-3K	-733.33%-75K	-4,080.00%-209K	-5,400.00%-385K
Net investment purchase and sale	-180.93%-174.67M	66.16%-21.04M	--2.55M	---159.05M	--2.87M	---62.18M	---62.18M	--0	--0	--0
Cash from discontinued investing activities
Investing cash flow	-178.32%-174.92M	66.00%-21.14M	3,441.33%2.51M	-76,041.63%-159.14M	841.56%2.86M	-261,766.67%-62.85M	-2,072,533.33%-62.18M	-733.33%-75K	-4,080.00%-209K	-5,400.00%-385K
Financing cash flow
Cash flow from continuing financing activities	-95.52%29.52M	-97.00%13.68M	10,058.62%5.89M	-26.47%3.43M	-96.71%6.52M	7,300.21%659.51M	456.61M	-68.82%58K	-26.46%4.66M	8,185.12%198.18M
Net issuance payments of debt	----	----	----	----	----	--0	----	----	----	----
Net common stock issuance	--0	--0	--0	--0	--0	--645.51M	--455.03M	--0	--0	--190.48M
Proceeds from stock option exercised by employees	100.31%31.11M	749.94%13.68M	10,058.62%5.89M	-26.47%3.43M	-11.93%8.11M	74.25%15.53M	--1.61M	-68.82%58K	-26.46%4.66M	284.74%9.2M
Net other financing activities	-3.73%-1.59M	--0	--0	--0	-5.45%-1.59M	---1.53M	---25K	--0	--0	---1.5M
Cash from discontinued financing activities
Financing cash flow	-95.52%29.52M	-97.00%13.68M	10,058.62%5.89M	-26.47%3.43M	-96.71%6.52M	7,300.21%659.51M	--456.61M	-68.82%58K	-26.46%4.66M	8,185.12%198.18M
Net cash flow
Beginning cash position	126.68%771.74M	27.67%539.72M	30.92%563.86M	55.55%748.42M	126.68%771.74M	-27.21%340.45M	14.78%422.73M	3.36%430.71M	9.03%481.15M	-27.21%340.45M
Current changes in cash	-166.92%-293.18M	-113.54%-48.33M	-94.67%-24.37M	-290.43%-193.38M	-118.92%-27.09M	431.06%438.1M	1,179.15%356.95M	73.25%-12.52M	-115.57%-49.53M	585.76%143.19M
Effect of exchange rate changes	287.58%12.76M	99.24%-60K	-95.11%222K	1,070.96%8.83M	251.08%3.77M	-234.64%-6.8M	-252.05%-7.94M	383.75%4.54M	44.23%-909K	-181.52%-2.5M
End cash Position	-36.34%491.32M	-36.34%491.32M	27.67%539.72M	30.92%563.86M	55.55%748.42M	126.68%771.74M	126.68%771.74M	14.78%422.73M	3.36%430.71M	9.03%481.15M
Free cash flow	7.04%-148.03M	-9.31%-40.98M	-160.88%-32.81M	30.32%-37.76M	33.65%-36.48M	-12.74%-159.24M	-13.32%-37.48M	73.23%-12.58M	-84.88%-54.19M	-72.54%-54.99M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm